CAS: 522-51-0; 1,1'-(Decane-1,10-Diyl)Bis(4-Amino-2-Methylquinolin-1-Ium) Chloride

该化合物是一种四硝基铵化合物,其特性是其广泛频谱抗微生物性,似乎是白色的,白色以外的晶状粉,在水中可溶解,适合各种应用,特别是药品和个人护理产品;该化合物因具有对抗一系列细菌和真菌的效力而著称,因为它在抗菌剂和防腐剂中具有价值;氯化物通过干扰微生物细胞膜,导致细胞死亡而具有各种功能;它经常被用于喉咙叶,洗口液和局部抗菌剂;此外,它被调查用于治疗感染和消毒剂的潜在用途;虽然一般认为在使用时是安全的,但它会对某些个人造成刺激,特别是在敏感地区;与任何化学物质一样,适当的处理和遵守安全准则对于尽量减少与接触有关的风险至关重要.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

4-chloro-2-methylquinoline

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-6144897-A
    优先权日:1995-06-09
    标 题 :Control method for processes of synthesis of chemical products
    发明人:SELLIERS JACQUES DE
    权利人:SOLVAY
    摘要:PCT No. PCT/EP96/02408 Sec. 371 Date Dec. 9, 1997 Sec. 102(e) Date Dec. 9, 1997 PCT Filed Jun. 1, 1996 PCT Pub. No. WO96/41822 PCT Pub. Date Dec. 27, 1996A control method for a process of synthesis of at least one chemical product in an equipment comprising at least one reactor (R) which is assimilated to a mixed reactor, in which manipulated variables (GC) allow to act on the course of the process in order to make one or more variables related to the properties of the product and/or to the running of the process, which are called controlled variables (GR).

    专利号:US-10022366-B2
    优先权日:2013-04-23
    标 题:Extending and maintaining micropore viability of microneedle treated skin with lipid biosynthesis inhibitors for sustained drug delivery
    发明人:STINCHCOMB AUDRA L; GHOSH PRIYANKA
    权利人:STINCHCOMB AUDRA L; GHOSH PRIYANKA; UNIV MARYLAND; UNIV KENTUCKY RES FOUND
    摘要:Microneedles and their use as a physical skin permeation enhancement technique facilitate drug delivery across the skin in therapeutically relevant concentrations. Micropores created in the skin by MNs reseal because of normal healing processes of the skin, thus limiting the duration of the drug delivery window. Pore lifetime enhancement strategies can increase effectiveness of MNs as a drug delivery mechanism by prolonging the delivery window. Fluvastatin (FLU) was used to enhance pore lifetime by inhibiting the synthesis of cholesterol, a major component of the stratum corneum lipids. The skin recovered within a 30-45-min time period following the removal of occlusion, and there was no significant irritation observed due to the treatment compared to the control sites. Thus, it can be concluded that localized skin treatment with FLU can be used to extend micropore lifetime and deliver drugs for up to 7 days across MN-treated skin.

    专利号:US-7453011-B2
    优先权日:2001-12-07
    标题:Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
    发明人:CLIFFORD LINDA; VALASINAS ALDONIA L; BLOKHIN ANDREI V; SARKAR APARAJITA; BASU HIRAK S; REDDY VENODHAR K; MARTON LAURENCE J; WANG YU
    权利人:PROGEN PHARMACEUTICALS INC
    摘要:Conformationally restricted polyamine compounds useful in treatment of cancer and other diseases marked by abnormal cell proliferation are disclosed. Improved methods of synthesizing such compounds are also disclosed. In one method of the invention, a carbene-bearing or carbene equivalent-bearing compound is reacted with the double bond of an alkene compound to form a cyclopropyl ring as the first step in the synthesis.

    专利号:CN-106458847-A
    优先权日:2014-05-29
    标 题:Synthesis of Novel Diamine and Its Liquid Crystal Alignment Agent

    专利号:JP-2019501915-A
    优先权日:2015-12-30
    标 题 :Selective synthesis of cationic lipids

    专利号:AU-704563-B2
    优先权日:1995-06-09
    标 题:Control method for processes of synthesis of chemical products
    济南鸿康达化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hkdchem.com
    企业联系电话:19152058418👤
    📞济南鸿康达化工有限公司 ⚠️参考联系方式
    联系人:赵
    电话:19152058418
    手机:19152058418
    传真:QQ:3679490472
    邮箱:chem.sales2026@outlook.com
    通信地址: 济南市历城区华信路15号凯贝特大厦
    邮编: 250000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市历城区华信路15号凯贝特大厦
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京梅尔森医药技术开发有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bjmerson.com
    电话: 086-10-80484574,80483447👤
    📞北京梅尔森医药技术开发有限公司 ⚠️参考联系方式

    销售电话:086-10-80484574,80483447
    邮箱:sales@bjmerson.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    合肥合宇化学新材料有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.heyuchem.com
    企业联系电话:18019556684,18156889753,13615640567👤
    📞合肥合宇化学新材料有限公司 ⚠️参考联系方式
    联系人:王先生
    电话:18019556684,18156889753,13615640567
    手机:18019556684
    传真:0551-63845482
    邮箱:heyuchem@163.com
    通信地址: 安徽省合肥市高新区柏堰科技园杭埠路23号
    邮编: 230000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:安徽省合肥市高新区柏堰科技园杭埠路23号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Lopes dos Santos Santiago G, Grob P, Verstraelen H, Waser F, Vaneechoutte M. Susceptibility testing of Atopobium vaginae for dequalinium chloride. BMC Res Notes. 2012 Mar 19;5:151. doi: 10.1186/1756-0500-5-151.
    2: Weissenbacher ER, Donders G, Unzeitig V, Martinez de Tejada B, Gerber S, Halaška M, Špaček J; Fluomizin Study Group. A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety. Gynecol Obstet Invest. 2012;73(1):8-15. doi: 10.1159/000332398. Epub 2011 Dec 24. doi: 10.1007/s00404-015-3914-8. Epub 2015 Oct 27. Review.
    4: Timaner M, Bril R, Kaidar-Person O, Rachman-Tzemah C, Alishekevitz D, Kotsofruk R, Miller V, Nevelsky A, Daniel S, Raviv Z, Rotenberg SA, Shaked Y. Dequalinium blocks macrophage-induced metastasis following local radiation. Oncotarget. 2015 Sep 29;6(29):27537-54. doi: 10.18632/oncotarget.4826.

    合成参考文献


    摘要:Journal of Pharmaceutical Sciences., 82(231), 1993 []
    摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118
    参考文献:10.1021/jm950884a
    摘要:Campos Rosa J, Galanakis D, Ganellin CR, Dunn PM. Synthesis, molecular modeling, and K+ channel-blocking activity of dequalinium analogues having semirigid linkers. J Med Chem. 1996 Oct 11;39(21):4247–54. doi: 10.1021/jm950884a.
    参考文献:10.1007/bf02548431
    摘要:BEEUWKES H. The use of chlorhexidine. Antonie Van Leeuwenhoek. 1958;24(1):49–62. doi: 10.1007/bf02548431.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知